Reacta Healthcare develops diagnostic solutions and challenge meals for food allergy testing and clinical research.
Reacta Healthcare has raised $3.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Reacta Healthcare's investors include Development Bank of Wales, Praetura Ventures, Innovate UK, Acceleris Capital, Jon Moulton’s family office.
Reacta Healthcare is headquartered in Deeside, Australia.
Reacta Healthcare develops diagnostic solutions and challenge meals for food allergy testing and clinical research.
Reacta Healthcare is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reacta Healthcare — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/reacta-healthcare. Accessed September 30, 2026.
VCBacked. (2025). Reacta Healthcare — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/reacta-healthcare
{{cite web |title=Reacta Healthcare — Funding & Investors |url=https://www.vcbacked.co/company/reacta-healthcare |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated